Home

Organisation: Position: Deadline Date: Location:

FOCUS: THIS WEEK'S TOP STORIES

BREAKING NEWS

WEEKLY ROUNDUP

Suspension of top CMS official explained

The Council for Medical Schemes (CMS) has tried to allay fears about its internal processes following the suspension of a top official for alleged... February 20th, 2019

ANAESTHESIOLOGY

CARDIOLOGY

HIV/AIDS

HIV/AIDS CONTINUED

INFECTIOUS DISEASES

Vitamin D in the fight against multi-drug resistant TB

Vitamin D speeds up the clearance of tuberculosis (TB) bacteria from the lungs of people with multi-drug resistant TB, according to a study of 1,850 patients receiving antibiotic treatment. Lead researcher Professor Adrian Martineau from Queen Mary... February 20th, 2019

NEUROLOGY

NUTRITION

Heavily processed foods linked to earlier death risk

A team in France worked with more than 44,000 people in a study running from 2009 called NutriNet-Santé. The Guardian reports they looked at how much of their diet – and calories – was made up of “ultra-processed” foods – those made in... February 20th, 2019

ONCOLOGY

Aspirin reduces the risk of colorectal cancer by 40%

Colorectal cancer is the third most common cause of cancer deaths in the US and advanced colorectal polyps are a major risk factor. The US Preventive Services Task Force (USPSTF) concluded that aspirin reduces the risk of colorectal cancer by 40% as... February 20th, 2019

ORTHOPAEDICS

PAEDIATRICS

SPORT & EXERCISE MEDICINE

Body-building protein supplement has potential for brain harm

People taking the protein supplement L-norvaline - an ingredient widely used in body building supplements and promoted as a compound that can boost workouts and aid recovery - should be aware of its potential for brain harm, Australian scientists... February 20th, 2019

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.